Gary W. Herschman and Zachary Taylor, attorneys in the Health Care & Life Sciences practice, in the firm’s Newark office, were quoted in Bloomberg Health Law & Business News, in “Health-Care Deals Dip Slightly While Overall Pace Stays Hot,” by Christopher Brown.
Following is an excerpt:
The number of health-care and life-sciences transactions dipped a bit in July from the previous month, but the pace remains strong and the total could reach 2,900 by year’s end, said Larry Kocot of KPMG in Washington….
Life Sciences Runs Hot
The life sciences and pharmaceuticals sector continued to run hot in July, with 48 announced or closed deals for the month, and 300 for the year, Kocot said.…
Transactions could exceed 100 in the third quarter of 2021 amid concern about a possible capital gains tax increase being pushed by the Biden administration, said Gary Herschman of Epstein, Becker & Green in Newark, N.J.
Physicians are also looking for the security of being part of well-capitalized and professionally managed organizations, and to cash in on the market value of their practices, Herschman said.
Infertility Care Interest
Mergers and acquisitions within the infertility/reproductive-care sector continued to accelerate, with interest from both strategic and financial acquirers, including Webster Equity Partners, InTandem Capital Partners, Boston IVF, and Unified Women’s Healthcare….
Deal volume in the cannabis sector remained strong in July, with 19 announced or closed transactions, said Zachary Taylor of Epstein, Becker & Green in Newark. The 2021 total has reached 159 transactions, almost double that of the same period of last year, which saw 85.
Deals took place in 12 different states and across the full-spectrum of services, including therapeutics, beauty, cultivation, manufacturing, and dispensing, he said.
